Tarsus Pharmaceuticals, Inc. (TARS) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Bobak R. Azamian

President/CEO and Board Chair

—

$5.18M (10) scheduled

−$5.18M

1,709,403

3.90%

$136.77M

−2.7%

William J Phd Link

Director

—

$4.48M (13) scheduled

−$4.48M

94,487

0.2153%

$7.56M

−46.8%

Dianne C. Whitfield

Chief Human Resources Officer

—

$2.69M (8) scheduled

−$2.69M

35,028

0.0798%

$2.80M

+2.5%

Elizabeth Yeu Lin

Chief Medical Officer

—

$2.36M (11) scheduled

−$2.36M

16,177

0.0369%

$1.29M

−51.4%

Seshadri Neervannan

Chief Operating Officer

—

$2.00M (6) scheduled

−$2.00M

79,482

0.1811%

$6.36M

+18.2%

Jeffrey S Farrow

See Remarks

—

$1.32M (4)

−$1.32M

56,801

0.1294%

$4.54M

+213.2%

Aziz Mottiwala

Chief Commercial Officer

—

$892.53K (3)

−$892.53K

61,480

0.1401%

$4.92M

+11.5%

Bryan Wahl

General Counsel

—

$850.42K (3)

−$850.42K

63,959

0.1457%

$5.12M

+50.0%

Katherine Goodrich

Director

—

$183.38K (1) scheduled

−$183.38K

2,233

0.0051%

$178.66K

—

Andrew D. Goldberg

Director

—

19,654

0.0448%

$1.57M

+209.5%

Wendy L Yarno

Director

—

16,956

0.0386%

$1.36M

+63.8%

Bhaskar Chaudhuri

Director

—

11,654

0.0266%

$932.44K

+117.8%

David E I Pyott

Director

—

10,958

0.0250%

$876.75K

+16.9%

Scott W Morrison

Director

—

7,638

0.0174%

$611.12K

—

Tarsus Pharmaceuticals, Inc.

What the insiders did Net selling

By person